CD73-Mediated Formation of Extracellular Adenosine Is Responsible for Adenosine A<sub>2A</sub> Receptor-Mediated Control of Fear Memory and Amygdala Plasticity

CD73-Mediated Formation of Extracellular Adenosine Is Responsible for Adenosine A<sub>2A</sub> Receptor-Mediated Control of Fear Memory and Amygdala Plasticity

Adenosine A<sub>2A</sub> receptors (A<sub>2A</sub>R) control fear memory and the underlying processes of synaptic plasticity in the amygdala. In other brain regions, A<sub>2A</sub>R activation is ensured by ATP-derived extracellular adenosine formed by ecto-5′-nuc...

Full description

Bibliographic Details
Main Authors:	Ana Patrícia Simões, Francisco Q. Gonçalves, Daniel Rial, Samira G. Ferreira, João Pedro Lopes, Paula M. Canas, Rodrigo A. Cunha
Format:	Article
Language:	English
Published:	MDPI AG 2022-10-01
Series:	International Journal of Molecular Sciences
Subjects:	CD73 ecto-nucleotidases adenosine A<sub>2A</sub> receptors fear memory synaptic plasticity
Online Access:	https://www.mdpi.com/1422-0067/23/21/12826

Similar Items

The Ecto-5’-Nucleotidase/CD73 Inhibitor, α,β-Methylene Adenosine 5’-Diphosphate, Exacerbates Carrageenan-Induced Pleurisy in Rat
by: Elisabetta Caiazzo, et al.
Published: (2019-07-01)

Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
by: Maria Saigí, et al.
Published: (2023-12-01)

Increased ATP release and CD73-mediated adenosine A2A receptor activation mediate convulsion-associated neuronal damage and hippocampal dysfunction
by: Elisabete Augusto, et al.
Published: (2021-09-01)

Exacerbation of Allergic Airway Inflammation in Mice Lacking ECTO-5′-Nucleotidase (CD73)
by: Elisabetta Caiazzo, et al.
Published: (2020-11-01)

Low expression of CD39 and CD73 genes in centenarians compared with octogenarians
by: Almudena Crooke, et al.
Published: (2017-05-01)

Downregulation of CD73/A<sub>2A</sub>R-Mediated Adenosine Signaling as a Potential Mechanism of Neuroprotective Effects of Theta-Burst Transcranial Magnetic Stimulation in Acute Experimental Autoimmune Encephalomyelitis
by: Milorad Dragić, et al.
Published: (2021-06-01)

Expression and Regulation of CD73 during the Estrous Cycle in Mouse Uterus
by: Jihyun Lee, et al.
Published: (2021-08-01)

How Are Adenosine and Adenosine A<sub>2A</sub> Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
by: Akihisa Mori, et al.
Published: (2021-08-01)

Adenosine A<sub>2A</sub> Receptors Shut Down Adenosine A<sub>1</sub> Receptor-Mediated Presynaptic Inhibition to Promote Implementation of Hippocampal Long-Term Potentiation
by: Cátia R. Lopes, et al.
Published: (2023-04-01)

Guanosine-Mediated Anxiolytic-Like Effect: Interplay with Adenosine A<sub>1</sub> and A<sub>2A</sub> Receptors
by: Monica Frinchi, et al.
Published: (2020-12-01)

ATP as a Multi-target Danger Signal in the Brain
by: Ricardo J Rodrigues, et al.
Published: (2015-04-01)

A<sub>3</sub> Adenosine Receptor Antagonists with Nucleoside Structures and Their Anticancer Activity
by: Andrea Spinaci, et al.
Published: (2022-01-01)

Hypoxia Depresses Synaptic Transmission in the Primary Motor Cortex of the Infant Rat—Role of Adenosine A<sub>1</sub> Receptors and Nitric Oxide
by: Isabella Zironi, et al.
Published: (2022-11-01)

Pharmacology of Adenosine Receptors: Recent Advancements
by: Fabrizio Vincenzi, et al.
Published: (2023-09-01)

Unveiling the Role of Ecto-5′-Nucleotidase/CD73 in Astrocyte Migration by Using Pharmacological Tools
by: Marija Adzic, et al.
Published: (2018-03-01)

The Signaling Pathways Involved in the Anticonvulsive Effects of the Adenosine A<sub>1</sub> Receptor
by: Jeroen Spanoghe, et al.
Published: (2020-12-01)

Endothelial Effects of Simultaneous Expression of Human HO-1, E5NT, and ENTPD1 in a Mouse
by: Paulina Mierzejewska, et al.
Published: (2023-10-01)

Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors
by: Laura Schäkel, et al.
Published: (2020-09-01)

Lack of Ecto-5′-Nucleotidase Protects Sensitized Mice against Allergen Challenge
by: Elisabetta Caiazzo, et al.
Published: (2022-05-01)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A<sub>2B</sub> Receptor Binding Affinity
by: Marcel Lindemann, et al.
Published: (2021-05-01)

Antiplatelet Effects of Selected Xanthine-Based Adenosine A<sub>2A</sub> and A<sub>2B</sub> Receptor Antagonists Determined in Rat Blood
by: Monika Kubacka, et al.
Published: (2023-08-01)

Adenosine Receptors Profile in Fibromuscular Dysplasia
by: Claire Guiol, et al.
Published: (2022-11-01)

Expression and Impact of Adenosine A<sub>3</sub> Receptors on Calcium Homeostasis in Human Right Atrium
by: Carmen Tarifa, et al.
Published: (2023-02-01)

The Adenosine A<sub>2B</sub> Receptor Drives Osteoclast-Mediated Bone Resorption in Hypoxic Microenvironments
by: Helen J. Knowles
Published: (2019-06-01)

A<sub>2A</sub> Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer’s Disease
by: Stefania Gessi, et al.
Published: (2021-09-01)

Brain cortical injury induces changes in peripheral lymphocyte ectonucleotidase activities
by: Laketa Danijela, et al.
Published: (2013-01-01)

Development of a Radiofluorinated Adenosine A<sub>2B</sub> Receptor Antagonist as Potential Ligand for PET Imaging
by: Marcel Lindemann, et al.
Published: (2020-04-01)

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A<sub>2A</sub> and Dual A<sub>1</sub>/A<sub>2A</sub> Receptor Affinity
by: Michał Załuski, et al.
Published: (2023-09-01)

Regulation of Ecto-5´-Nucleotidase by Docosahexaenoic Acid in Human Endothelial Cells
by: Vu Thi Thom, et al.
Published: (2013-08-01)

Characterization and Seasonal Modulation of Adenosine A<sub>1</sub> Receptors in the Arctic Ground Squirrel Brain
by: Zachary Carlson, et al.
Published: (2023-01-01)

Allosteric Antagonism of the A<sub>2A</sub> Adenosine Receptor by a Series of Bitopic Ligands
by: Zhan-Guo Gao, et al.
Published: (2020-05-01)

Adenosine A<sub>3</sub> Receptor (A<sub>3</sub>AR) Agonist for the Treatment of Bleomycin-Induced Lung Fibrosis in Mice
by: Silvia Sgambellone, et al.
Published: (2022-11-01)

Adenosine A<sub>2A</sub> Receptor Up-Regulation Pre-Dates Deficits of Synaptic Plasticity and of Memory in Mice Exposed to Aβ<sub>1–42</sub> to Model Early Alzheimer’s Disease
by: Cátia R. Lopes, et al.
Published: (2023-07-01)

Extracellular adenosine-mediated modulation of regulatory T cells
by: Akio eOhta, et al.
Published: (2014-07-01)

Adenosine A<sub>2A</sub>Receptors in Substance Use Disorders: A Focus on Cocaine
by: Karolina Wydra, et al.
Published: (2020-06-01)

Adenosine A<sub>2A</sub> receptor activation reduces recurrence and mortality from <it>Clostridium difficile</it> infection in mice following vancomycin treatment
by: Li Yuesheng, et al.
Published: (2012-12-01)

ROLE OF PURINE METABOLISM ENZYMES IN IMMUNE PATHOGENESIS OF FIBRO-CAVERNOUS PULMONARY TUBERCULOSIS
by: M. Ye. Dyakova, et al.
Published: (2016-04-01)

Analysis of the NTPDase and ecto-5'-nucleotidase profiles in serum-limited Trichomonas vaginalis
by: Amanda Piccoli Frasson, et al.
Published: (2012-03-01)

Activation of Adenosine A<sub>3</sub> Receptor Inhibits Microglia Reactivity Elicited by Elevated Pressure
by: Joana Ferreira-Silva, et al.
Published: (2020-09-01)

Adenosine Receptor Antagonists to Combat Cancer and to Boost Anti-Cancer Chemotherapy and Immunotherapy
by: Rafael Franco, et al.
Published: (2021-10-01)